Page Title
Clinical Trial Finder
You can help advance cystic fibrosis research — starting now.
Tailor your search using the filters on the left.
Need help? Watch a video tutorial or contact the Clinical Trial Navigator, a real person who can assist you.
Showing 1-1 of 1 studies
Tailor your search using the filters on the left.
Need help? Watch a video tutorial or contact the Clinical Trial Navigator, a real person who can assist you.
Showing 1-1 of 1 studies
-
Restore CFTR ProteinCompleted with Results
RESTORE-CF: Phase 1/2 study of MRT5005 drug in adults with cystic fibrosis (Parts A, B and B Expansion) , protocol number Translate Bio MRT5005-101This study evaluated the safety, tolerability, and biological activity of MRT5005 in adults with Cystic Fibrosis who have either two Class I or two Class II CFTR gene mutations.
-
Age:
18 Years and Older
-
Mutation(s):
Mutation Requirement
-
FEV1% Predicted:
50 to 90%
-
Number of Visits:
21
-
Length of Participation:
1 years
-
Showing 1-1 of 1 studies
- 1
Studies in this tool are multi-center studies facilitated by the Cystic Fibrosis Therapeutics Development Network. For a complete list of cystic fibrosis related studies, visit www.clinicaltrials.gov.
Related Topics
CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More